ALBOU Fundamental Analysis - BOURRELIER GROUP

Fundamental Rating

Overall ALBOU gets a fundamental rating of 3 out of 10. We evaluated ALBOU against 57 industry peers in the Specialty Retail industry. ALBOU scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALBOU has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALBOU was profitable.

In the past 5 years ALBOU has always been profitable.

ALBOU had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

ALBOU has a Return On Assets (0.38%) which is comparable to the rest of the industry.

ALBOU's Return On Equity of 0.61% is in line compared to the rest of the industry. ALBOU outperforms 42.11% of its industry peers.

		Industry Rank	Sector Rank
ROA	0.38%
ROE	0.61%
ROIC	N/A

ROA(3y)0.88%

ROA(5y)1.87%

ROE(3y)1.44%

ROE(5y)2.95%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin of ALBOU (0.73%) is comparable to the rest of the industry.

In the last couple of years the Profit Margin of ALBOU has declined.

Looking at the Gross Margin, with a value of 39.09%, ALBOU is in line with its industry, outperforming 57.89% of the companies in the same industry.

In the last couple of years the Gross Margin of ALBOU has grown nicely.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	0.73%
GM	39.09%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-54.12%

PM growth 5YN/A

GM growth 3Y-0.58%

GM growth 5Y2.23%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALBOU does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, ALBOU has about the same amount of shares outstanding.

The number of shares outstanding for ALBOU remains at a similar level compared to 5 years ago.

The debt/assets ratio for ALBOU is higher compared to a year ago.

2.2 Solvency

ALBOU has an Altman-Z score of 2.55. This is not the best score and indicates that ALBOU is in the grey zone with still only limited risk for bankruptcy at the moment.

ALBOU has a better Altman-Z score (2.55) than 73.68% of its industry peers.

A Debt/Equity ratio of 0.38 indicates that ALBOU is not too dependend on debt financing.

ALBOU has a better Debt to Equity ratio (0.38) than 71.93% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.38
Debt/FCF	N/A
Altman-Z	2.55

ROIC/WACCN/A

WACC6.54%

2.3 Liquidity

ALBOU has a Current Ratio of 4.75. This indicates that ALBOU is financially healthy and has no problem in meeting its short term obligations.

ALBOU has a better Current ratio (4.75) than 98.25% of its industry peers.

ALBOU has a Quick Ratio of 3.25. This indicates that ALBOU is financially healthy and has no problem in meeting its short term obligations.

The Quick ratio of ALBOU (3.25) is better than 94.74% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	4.75
Quick Ratio	3.25

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALBOU have decreased strongly by -38.38% in the last year.

ALBOU shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -53.90% yearly.

The Revenue has been growing slightly by 1.78% in the past year.

The Revenue has been growing slightly by 6.13% on average over the past years.

EPS 1Y (TTM)-38.38%

EPS 3Y-53.9%

EPS 5YN/A

EPS Q2Q%580.17%

Revenue 1Y (TTM)1.78%

Revenue growth 3Y0.49%

Revenue growth 5Y6.13%

Sales Q2Q%-0.51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 128.00, ALBOU can be considered very expensive at the moment.

Based on the Price/Earnings ratio, ALBOU is valued a bit more expensive than the industry average as 61.40% of the companies are valued more cheaply.

ALBOU's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.31.

		Industry Rank	Sector Rank
PE	128
Fwd PE	N/A

4.2 Price Multiples

ALBOU's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ALBOU is cheaper than 78.95% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	4.46

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALBOU!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BOURRELIER GROUP

EPA:ALBOU (11/27/2025, 7:00:00 PM)

44.8

-0.2 (-0.44%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustrySpecialty Retail

Earnings (Last)07-18 2025-07-18

Earnings (Next)02-26 2026-02-26

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap278.66M

Revenue(TTM)300.14M

Net Income(TTM)2.18M

Analysts34.29

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend3.2

Dividend Growth(5Y)26.19%

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	128
Fwd PE	N/A
P/S	0.93
P/FCF	N/A
P/OCF	N/A
P/B	0.78
P/tB	0.89
EV/EBITDA	4.46

EPS(TTM)0.35

EY0.78%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS48.25

BVpS57.7

TBVpS50.34

PEG (NY)N/A

PEG (5Y)N/A

Graham Number21.32

Profitability

		Industry Rank	Sector Rank
ROA	0.38%
ROE	0.61%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	0.73%
GM	39.09%
FCFM	N/A

ROA(3y)0.88%

ROA(5y)1.87%

ROE(3y)1.44%

ROE(5y)2.95%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-54.12%

PM growth 5YN/A

GM growth 3Y-0.58%

GM growth 5Y2.23%

F-ScoreN/A

Asset Turnover0.53

Health

		Industry Rank	Sector Rank
Debt/Equity	0.38
Debt/FCF	N/A
Debt/EBITDA	5.42
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	4.75
Quick Ratio	3.25
Altman-Z	2.55

F-ScoreN/A

WACC6.54%

ROIC/WACCN/A

Cap/Depr(3y)49.74%

Cap/Depr(5y)37.12%

Cap/Sales(3y)4.81%

Cap/Sales(5y)3.48%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-38.38%

EPS 3Y-53.9%

EPS 5YN/A

EPS Q2Q%580.17%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)1.78%

Revenue growth 3Y0.49%

Revenue growth 5Y6.13%

Sales Q2Q%-0.51%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-517.44%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-163.96%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-24.8%

OCF growth 3Y3.54%

OCF growth 5Y-15.14%

BOURRELIER GROUP / ALBOU.PA FAQ

Can you provide the ChartMill fundamental rating for BOURRELIER GROUP?

ChartMill assigns a fundamental rating of 3 / 10 to ALBOU.PA.

What is the valuation status for ALBOU stock?

ChartMill assigns a valuation rating of 1 / 10 to BOURRELIER GROUP (ALBOU.PA). This can be considered as Overvalued.

Can you provide the profitability details for BOURRELIER GROUP?

BOURRELIER GROUP (ALBOU.PA) has a profitability rating of 3 / 10.

Can you provide the PE and PB ratios for ALBOU stock?

The Price/Earnings (PE) ratio for BOURRELIER GROUP (ALBOU.PA) is 128 and the Price/Book (PB) ratio is 0.78.

BOURRELIER GROUP (ALBOU.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

BOURRELIER GROUP / ALBOU.PA FAQ

Can you provide the ChartMill fundamental rating for BOURRELIER GROUP?

What is the valuation status for ALBOU stock?

Can you provide the profitability details for BOURRELIER GROUP?

Can you provide the PE and PB ratios for ALBOU stock?